Halozyme Therapeutics | HALO - Trade Creditors

Stock Price
80.82
Daily Change
2.40 3.06%
Monthly
7.60%
Yearly
41.54%
Q1 Forecast
69.50

Halozyme Therapeutics reported $15.36M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Acadia Pharmaceuticals USD 21.75M 1.65M Sep/2025
Agios Pharmaceuticals USD 19.55M 2.02M Sep/2025
Alnylam Pharmaceuticals USD 117.59M 15.2M Sep/2025
Amarin USD 36.71M 8M Sep/2025
Amgen USD 19.64B 1.61B Sep/2025
Baxter International USD 953M 42M Sep/2025
Cytokinetics USD 22.08M 46.46M Sep/2025
DBV Technologies USD 39.82M 972K Sep/2025
Eli Lilly USD 4.26B 186.5M Sep/2025
Halozyme Therapeutics USD 15.36M 3.33M Sep/2025
Ionis Pharmaceuticals USD 14.33M 8.47M Sep/2025
MannKind USD 7.27M 2.99M Sep/2025
Pfizer USD 5.02B 142M Sep/2025
United Therapeutics USD 468M 36M Sep/2025